Management of Postoperative Atrial Fibrillation

Paul Bailey, MD, and Peter Zimetbaum, MD

Supported by educational grants from Bristol-Myers Squibb Company and Pfizer, Inc.

SUMMARY

Atrial fibrillation (AF) is the most common arrhythmia in the postoperative period. It is important that hospitalists understand the current management of postoperative AF because it is a frequent reason for consultation. Moreover, there can be significant clinical implications including reduced quality of life due to symptoms, increased risk of ischemic stroke, increased length of stay, and an association with potentially serious postoperative complications, such as sepsis, leading to increased mortality. The following module addresses the incidence, risk factors, natural history, evaluation, prevention, and management of postoperative AF.

GOAL
To provide hospitalists with current information and guidelines for the evaluation and management of postoperative AF.
 
TARGET AUDIENCE
This activity is designed for hospitalists. 
 
LEARNING OBJECTIVES
After completing the module, the participant should be able to:
1. Identify the risk factors for postoperative AF and the pharmacologic prophylactic strategies used to prevent postoperative AF.
2. Describe the clinical implications of postoperative AF. 
3. Discuss the evaluation of postoperative AF. 
4. Propose a management plan for postoperative AF.
 
CME INFORMATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Virginia School of Medicine, ASiM and the Society of Hospital Medicine. The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians
 
The University of Virginia School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.   
 
Release date:  October 30, 2015                 Expiration date: October 30, 2018
 
 
Estimated time to complete activity: 2 hours
 
FACULTY & FACULTY DISCLOSURES
Full Disclosure Policy Affecting CME Activities:
The University of Virginia School of Medicine, as an ACCME accredited provider, endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices.
 
The University of Virginia School of Medicine requires that all CME activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.
 
All faculty presenters participating in an accredited CME activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.). The University of Virginia School of Medicine will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant. Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine, Charlottesville, Virginia.
 
The faculty and staff of the University of Virginia Office of Continuing Medical Education and at ASiM have no financial affiliations to disclose.
 
The following relationships have been reported for faculty of this activity: 
 
Leonard Feldman, MD, FACP, FAAP, SFHM (Chair) 
Assistant Professor of Medicine and Pediatrics 
Johns Hopkins University School of Medicine 
Med-Peds Urban Health Residency Program Director
Associate Program Director, Osler Medical Residency
Director, Comprehensive General Medicine Consult Service
Editor, Consultative and Perioperative Medicine Essentials for Hospitalists
Baltimore, Maryland
Dr Feldman reports having no significant financial or advisory relationships with corporate organizations related to this activity.
 
Paul M. Bailey, MD 
Hospital Medicine Program
Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Dr Bailey reports having no significant financial or advisory relationships with corporate organizations related to this activity. 
 
Peter Zimetbaum, MD
Director of Clinical Cardiology
Beth Israel Deaconess Medical Center
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Dr Zimetbaum reports serving as a consultant to perform clinical research for  Medtronic. 
 
Lawrence W. Gimple, MD (Peer Reviewer)
Director, Clinical Cardiology
Director, Coronary Care Unit
Professor of Medicine
University of Virginia Health System
Charlottesville, Virginia
Dr Gimple reports having no significant financial or advisory relationships with corporate organizations related to this activity.
 
Disclosure of Discussion of Non-FDA–Approved Uses for Pharmaceutical Products and/or Medical Devices
The University of Virginia School of Medicine, as an ACCME provider, requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The University of Virginia School of Medicine recommends that each physician fully review all the available data on new products or procedures prior to clinical use.
 
All faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.
 
DISCLAIMER
The opinions and recommendations expressed by faculty and other experts are based on current scientific evidence and standards of care and their professional expertise. This enduring material is produced for educational purposes only.  The University of Virginia School of Medicine implements specific educational planning processes to ensure that content is patient-centric and independent. The University of Virginia School of Medicine recommends that each physician fully review all the available data on new products or procedures prior to clinical use.
 
Click here to download the references for this educational activity.
 
INSTRUCTIONS
The following is an interactive educational module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: a nondesignated pre-test, a study program, and a CME post-test. All 3 sections must be completed to receive CME credit. 
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation (non-CME)
Course opens: 
10/30/2015
Course expires: 
10/30/2018
Non-member cost:
$0.00
Parent activity set: 
Rating: 
0

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation (non-CME)

Accreditation Period

Course opens: 
10/30/2015
Course expires: 
10/30/2018

Price

Non-member cost:
$0.00
Please login or register to take this course.